###begin article-title 0
Birth Prevalence of Homocystinuria in Central Europe: Frequency and Pathogenicity of Mutation c.1105C>T (p.R369C) in the Cystathionine Beta-Synthase Gene
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Objectives
###end title 2
###begin p 3
To estimate the frequency of the cystathionine beta-synthase deficiency caused by c.1105C>T mutation in Central Europe compared to Norway, and to examine the pathogenicity of the corresponding p.R369C mutant enzyme.
###end p 3
###begin title 4
Study design
###end title 4
###begin p 5
Mutation c.1105C>T was analyzed in 600 anonymous Czech newborn blood spots. Catalytic activity and quaternary structure of the p.R369C mutant was evaluated after expression in 2 cellular systems.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 198 214 198 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 458 459 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 499 502 499 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 198 214 <span type="species:ncbi:562">Escherichia coli</span>
###xml 302 317 <span type="species:ncbi:10029">Chinese hamster</span>
Population frequency of the c.1105C>T mutation was 0.005, predicting the birth prevalence of homocystinuria of 1:40 000, which increased to 1:15 500 in a model including 10 additional mutations. In Escherichia coli the p.R369C mutant misfolded, and its activity was severely reduced, and expression in Chinese hamster ovary cells enabled proper folding with activity decreased to 63% of the wild-type enzyme. This decreased activity was not due to impaired Km for both substrates but resulted from Vmax lowered to 55% of the normal cystathionine beta-synthase enzyme.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
The c.1105C>T (p.R369C) allele is common also in the Czech population. Although the p.R369C mutation impairs folding and decreases velocity of the enzymatic reaction, our data are congruent with rather mild clinical phenotype in homozygotes or compound heterozygotes carrying this mutation.
###end p 9
###begin title 10
Abbreviations
###end title 10
###begin p 11
###xml 238 241 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1,2</sup>
###xml 238 241 238 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1 bib2" ref-type="bibr"><sup>1,2</sup></xref>
###xml 335 338 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3-6</sup>
###xml 335 338 335 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3 bib4 bib5 bib6" ref-type="bibr"><sup>3-6</sup></xref>
Homocystinuria caused by cystathionine beta synthase (CBS) deficiency is a rare autosomal recessive disorder of sulfur amino acid metabolism. The disease manifests in childhood by vascular, neurologic, and connective tissue abnormalities,1,2 although increasing numbers of mildly affected adults with only thromboembolism are reported.3-6
###end p 11
###begin p 12
###xml 343 344 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 398 399 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 398 399 398 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr"><sup>8</sup></xref>
###xml 587 591 587 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9-11</sup>
###xml 587 591 587 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9 bib10 bib11" ref-type="bibr"><sup>9-11</sup></xref>
###xml 637 639 637 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 996 998 996 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 996 998 996 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 282 290 <span type="species:ncbi:9606">patients</span>
###xml 924 931 <span type="species:ncbi:9606">patient</span>
Various approaches have been used to examine the population frequency of homocystinuria, but the true incidence of the disease is unknown. Newborn screening, based on finding individuals with elevated blood methionine concentrations, has apparently been detected almost exclusively patients with severe pyridoxine nonresponsive form of disease7 and with a worldwide incidence of 1:65 000-1:900 000.8 However, estimates calculated from the heterozygote frequency for the most common mutation c.833T>C (p.I278T) in newborns suggested an incidence of at least one order of magnitude higher.9-11 In agreement with these findings Refsum et al12 reported even higher population frequency of another CBS mutation c.1105 C>T, which was present in 0.8% of CBS chromosomes among unselected Norwegian newborns. The calculated incidence of homocystinuria caused by 6 mutations including the c.1105 C>T may be thus unusually high with 1 patient with CBS deficiency expected in each of 6400 Norwegian newborns.12
###end p 12
###begin p 13
###xml 315 317 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 315 317 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 324 326 324 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
###xml 343 344 343 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr"><sup>4</sup></xref>
###xml 410 417 410 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table I</xref>
###xml 442 444 442 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 293 301 <span type="species:ncbi:9606">patients</span>
###xml 457 462 <span type="species:ncbi:4932">yeast</span>
The c.1105 C>T mutation is localized in a CpG dinucleotide in exon 10 and leads to replacement of arginine in position 369 of the CBS polypeptide by cysteine (p.R369C). The pathogenicity of this mutation is unclear. The c.1105 C>T was originally described in 3 unrelated pyridoxine-responsive patients of Norwegian,14 Dutch,13 and Anglo-Celtic4 origin, which strongly supports the notion of its pathogenicity (Table I). In contrast, Kim et al14 showed in a yeast system that expression of the p.R369C variant ensures normal to above-normal growth of CBS-deficient strain, suggesting none or at most a mild effect of p.R369C on the enzyme activity.
###end p 13
###begin p 14
High frequency of the c.1105 C>T allele and its putative pathogenicity may have important epidemiologic consequences, such as for neonatal screening of homocystinuria. Our study was therefore aimed at (1) determining the frequency of this variant in another Caucasian population and (2) examining the pathogenicity of the p.R369C mutant by expression studies in prokaryotic and eukaryotic systems.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Samples
###end title 16
###begin p 17
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
We used 300 anonymous peripheral blood spots from Prague and 300 archived umbilical cord blood samples from Brno representing Bohemian and Moravian region, respectively, from a study that was described previously.10 Genomic DNA was isolated with the QIAamp DNA Mini Kit (Qiagen, Valencia, California). This study was approved by the Ethics Committee of Charles University in Prague-First Faculty of Medicine.
###end p 17
###begin title 18
Genotyping
###end title 18
###begin p 19
To detect the c.1105C>T alleles, we used polymerase chain reaction (PCR)-RFLP technique to amplify exon 10 from genomic DNA using specific primers-forward: 5'-CAgTgCCCACCCCAgCTCATTA-3' and reverse: 5'-ggCCTCCTCCCCTCCCAgTTCT-3' and Klentaq polymerase (GeneAge Technologies, Praha, Czech Republic).
###end p 19
###begin p 20
###xml 9 11 9 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 9 11 9 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hae</italic>
###xml 317 320 317 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hha</italic>
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hha</italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cac8</italic>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dra</italic>
Kim et al14 used HaeII for PCR-RFLP analysis of c.1105 C>T (p.R369C); however, the loss of restriction site in their assay may be also caused by the mutation c.1106 G>A (p.R369H). To explore the possibility that either c.1105 C>T or c.1106 G>A was present in Czech newborns, the PCR products were first digested with HhaI to detect these 2 mutant alleles. The HhaI-positive samples were further digested with Cac8I and DraIII to check for the presence of c.1105 C>T and c.1106 G>A mutation, respectively. The latter mutation was not detected in the studied cohort.
###end p 20
###begin title 21
Expression Constructs
###end title 21
###begin p 22
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr"><sup>15</sup></xref>
Both the wild-type CBS and the mutant c.1105C>T constructs were derived from pHCS3 expression plasmid.15 The mutation was introduced into the wild-type expression plasmid with GeneTailor Site-directed mutagenesis kit (Invitrogen, Carlsbad, California) on the basis of manufacturer procedure. The sequences of mutagenic primers for c.1105 C>T were as follow-sense: 5'-gCTgCgTggTCATTCTgCCCgACTCagTgC-3' and antisense: 5'-gCAgAATgACCACgCAgCACTggCCCTCCT-3'.
###end p 22
###begin p 23
For the purpose of eukaryotic expression both the wild-type and c.1105 C>T containing CBS were cloned into pTRE2hyg vector (Clontech Laboratories, Mountain View, California). The presence of c.1105 C>T and the absence of additional mutations in the entire coding CBS sequence of the pHCS3 and pTRE2hyg constructs were verified by dideoxy sequencing with ALF sequencer (Amersham Pharmacia Biotech, Piscataway, New Jersey).
###end p 23
###begin title 24
Prokaryotic Expression
###end title 24
###begin p 25
###xml 265 268 252 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">600</sub>
###xml 583 599 543 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 787 789 747 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 787 789 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr"><sup>15</sup></xref>
###xml 868 870 828 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sup>
###xml 868 870 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr"><sup>16</sup></xref>
###xml 583 599 <span type="species:ncbi:562">Escherichia coli</span>
###xml 876 882 <span type="species:ncbi:9913">bovine</span>
Both the wild-type and p.R369C CBS enzymes were expressed in DH5alpha cells (Gibco BRL, Carlsbad, California). The cells were grown at 37degrees C or 18degrees C, respectively, in Super Optimal Broth (SOB) media supplemented with ampicillin 100 mug/mL. After the OD600 of cultures reached approximately0.5, the cells were induced with isopropyl beta-D-1-thiogalactopyranoside (final concentration 0.33 mmol/L) and grown for an additional 3 hours or overnight at 37degrees C or 18degrees C, respectively. The pKK vector without CBS insert was used as a negative control. Lysates from Escherichia coli cell pellets were prepared by sonication in Tris-Cl buffer with addition of Protease Inhibitor Cocktail suitable for use with bacterial cell extracts (Sigma Aldrich, St. Louis, Missouri).15 Concentration of protein in lysates was determined as described by Lowry et al16 with bovine serum albumin used as a standard. All expressions were done in triplicate, and the numbers shown in this article represent means.
###end p 25
###begin title 26
Eukaryotic Expression in CHO-K1 Cells
###end title 26
###begin p 27
###xml 140 141 140 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 761 763 761 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sup>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr"><sup>17</sup></xref>
###xml 160 175 <span type="species:ncbi:10029">Chinese hamster</span>
###xml 390 395 <span type="species:ncbi:9606">human</span>
Because the CHO-K1 cells do not express endogenous CBS at significant levels, they are a suitable system for studying CBS mutants. Two 75-cm2 flasks containing Chinese hamster ovary-derived cells that express the reverse tetracycline-controlled transactivator (BD Biosciences, San Jose, California) were transiently transfected with pTRE-2hyg plasmid bearing either the wild-type or mutant human CBS sequences with Lipofectamine-2000 (Invitrogen, Carlsbad, California). The CBS expression was induced 4 hours after transfection with doxycycline (final concentration 200 ng/mL). About 20 hours after transfection the cells were harvested mechanically and pooled, cell extracts were prepared by osmotic lysis with phosphate buffer 30 mmol/L with PEE-W1 detergent,17 and protein concentration was determined as described above. All expressions were done in triplicate, and means are shown in the article. For kinetic studies large-scale expression was carried out, and higher variability in the amounts of mutant tetramers in lysates was observed (data not shown).
###end p 27
###begin title 28
CBS Activity and Kinetics Measurement
###end title 28
###begin p 29
###xml 113 115 113 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr"><sup>15</sup></xref>
###xml 162 169 156 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 264 266 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 264 266 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 299 300 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 402 403 396 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 162 169 <span type="species:ncbi:562">E. coli</span>
The CBS activity was assayed at homocysteine 10 mmol/L and serine 10 mmol/L by the previously published procedure15 with incubation at 37degrees C for 1 hour for E. coli lysates and 4 hours for CHO lysates with the following modification: mixture of unlabeled and 14C-labeled serine was replaced by 2H-labeled serine 10 mmol/L (Cambridge Isotope Laboratories, Andover, Massachusetts) and the amount of 2H-labeled cystathionine produced was determined by LC-MS-MS with a commercially available kit for amino acid analysis (EZ:faast; Phenomenex, Torrance, California) (Krijt et al, unpublished data).
###end p 29
###begin p 30
###xml 309 310 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 471 472 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 478 481 470 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
The kinetic studies were performed in CHO lysates (approximately 30 to 40 mug of total cellular protein in 50 muL reaction) incubated for 30 minutes at 37degrees C. The above-described assay procedure was used maintaining one substrate at saturating concentration (40 mmol/L and 20 mmol/L of homocysteine and 2H-labeled serine, respectively) while using the concentration of the other substrate of 0.31, 0.62, 1.25, 2.5, 5, 7.5, 10, 12.5, 15, 20, 30, and 40 mmol/L. The Km and Vmax were calculated with KaleidaGraph software (Synergy Software, Reading, Pennsylvania).
###end p 30
###begin title 31
Western Blot Analysis
###end title 31
###begin p 32
###xml 612 618 <span type="species:ncbi:9913">bovine</span>
###xml 778 784 <span type="species:ncbi:9986">rabbit</span>
For Western blot analysis, cell lysates containing total protein 10 mug were electrophoresed on 4% to 15% gradient native polyacrylamide gels (BioRad precast gels) with Laemmli buffer system with or without SDS for SDS-PAGE and native-PAGE gel, respectively. The separated proteins were transferred onto polyvinylidene difluoride membrane (Immobilon-P; Millipore, Billerica, Massachusetts) with semi-dry blotting transfer technique. After transfer and overnight blocking of nonspecific binding sites with 5% non-fat dry milk, the membrane was incubated with immunopurified anti-CBS antibody diluted 1:5000 in 3% bovine serum albumin in 1 x phosphate-buffered saline solution (PBS) for 1 hour. After a series of washes the membrane was subsequently incubated with secondary anti-rabbit IgG antibody conjugated with HRP for 30 minutes (Pierce, Rockford, Illinois); the secondary antibody was diluted 1:30 000 in 5% non-fat dry milk dissolved in 1 x PBS/0.2% Tween 20. After a second series of washes the signal was visualized using the West Pico Super Signal system (Pierce Biotechnology, Rockford, Illinois) followed by bioimaging system ChemiGenius-Q (Syngene Inc, Frederick, Maryland) with cooled CCD camera. The amount of tetramers and high-molecular weight aggregates were quantified with Gene Tools software (Syngene Inc).
###end p 32
###begin title 33
Statistical Methods
###end title 33
###begin p 34
###xml 117 119 117 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
Expected birth prevalence was calculated on the basis of Hardy-Weinberg equilibrium with a model published previously10 with added frequency of the c.1105C>T alleles. Confidence intervals of estimates were calculated with S-plus (Tibco Software, Inc, Palo Alto, California) and R software.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
Frequency of the c.1105C>T Mutation and Expected Birth Prevalence of Homocystinuria
###end title 36
###begin p 37
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 530 532 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 530 532 530 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
###xml 737 745 <span type="species:ncbi:9606">patients</span>
We detected six c.1105C>T heterozygotes among 600 unselected Czech newborns; 1 individual was present in the Bohemian cohort and 5 in the Moravian cohort, respectively. The observed allelic frequency of c.1105C>T is 0.005 (95%CI 0.0018-0.011), which is similar to that observed in Norway.12 Assuming Hardy-Weinberg equilibrium the expected birth prevalence of homozygotes for this mutation is 1:40 000 (95%CI 1:8000-1:295 000). We have previously estimated incidence of homocystinuria in the Czech Republic with a composite model.10 In the model we have combined direct detection of 2 mutant alleles in unselected newborn blood samples with an inferred population frequency of 8 additional mutant alleles calculated from their number in patients who were ascertained by biochemical screening during a 20-year period. After adding the data on c.1105C>T from this study into the above-mentioned composite model, the expected birth prevalence of homocystinuria in the Czech Republic increased to 1:15 500 newborns (95% CI 1:7500-1:38 000).
###end p 37
###begin title 38
In Silico Analyses of the p.R369C Mutant
###end title 38
###begin p 39
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sup>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr"><sup>18</sup></xref>
###xml 158 160 158 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">19</sup>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr"><sup>19</sup></xref>
Arginine 369 is located in the beta strand 11 at a dimer-dimer interface of the CBS enzyme.18 In their 3-dimensional model of full-length CBS, Yamanishi et al19 predicted that this mutation abolishes an ionic interaction with D506 residue located in the carboxyterminal regulatory CBS domain, suggesting possible destabilization of tertiary structure. Analysis with Clustal-W and a series of CBS orthologs obtained from NCBI database showed that arginine 369 is highly conserved in mammals, and in other organisms, this positively charged amino acid may be replaced by positively charged lysine or uncharged tyrosine, valine, leucine, methionine or asparagine residues but not by cysteine (data not shown). This imperfect conservation of arginine in position 369 of the CBS polypeptide during evolution suggests that this amino acid residue is not absolutely critical for cystathionine beta-synthase function. Taken together these computer-simulated data suggest that the effect of this mutation on enzyme function may be rather mild.
###end p 39
###begin title 40
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 42 49 <span type="species:ncbi:562">E. coli</span>
Properties of p.R369C Mutant Expressed in E. coli
###end title 40
###begin p 41
###xml 543 549 537 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure</xref>
###xml 704 712 698 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table II</xref>
The p.R369C mutant expressed at 37degrees C was present in bacterial extracts in amounts somewhat lower than the wild-type enzyme (66 % of CBS signal relative to the wild-type upon analysis by denaturing SDS-PAGE/western blotting; data not shown). Most of these mutant enzyme molecules misfolded, as demonstrated by the presence of only 8% of correctly folded tetrameric fraction of the p.R369C relative to the wild-type CBS enzyme when non-denaturing conditions for PAGE/Western blotting were used and data were normalized for CBS abundance (Figure). The relative activity-that is, specific activity normalized for the abundance of tetramers-of the p.R369C mutant was decreased to 34% of the wild-type (Table II).
###end p 41
###begin p 42
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sup>
###xml 23 25 23 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr"><sup>20</sup></xref>
###xml 413 421 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table II</xref>
It was shown previously20 that lower expression temperature may facilitate the attainment of correct tertiary and quaternary structure of misfolding-prone mutants. Indeed, folding and assembly of mutant p.R369C polypeptide chains expressed at 18degrees C improved substantially as the bacterial extracts contained 23% of tetramer compared with wild-type and the relative activity simultaneously increased to 67% (Table II). To examine whether the p.R369C mutation may alter the response to the natural allosteric activator of CBS-S-adenosylmethionine (SAM)-we measured the catalytic activity of the mutant expressed at 18degrees C in the absence and presence of 1 mmol/L SAM. The activity of the mutant increased 4.4 times in the presence of SAM, which is similar to the increase of 5.7 for the wild-type enzyme; these data demonstrate that the mutant enzyme retains its normal allosteric activation by S-adenosylmethionine.
###end p 42
###begin p 43
###xml 686 688 686 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21</sup>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr"><sup>21</sup></xref>
###xml 673 678 <span type="species:ncbi:9606">human</span>
The above data show that the p.R369C CBS mutant is intrinsically prone to misfolding with simultaneous loss of activity, and that this property may be reversed by folding permissive conditions. Moreover, the expression studies demonstrated that even the correctly folded and assembled tetramers exhibit only 34% to 67% relative activity per tetramer amount compared with the wild-type enzyme. It was shown previously that despite their limitations the prokaryotic expression systems permit examination of intrinsic properties of mutant enzymes such as cytosolic phenylalanine hydroxylase, and expression in mammalian systems mimics more faithfully the in vivo situation in human beings.21 Therefore we subsequently tested the properties of the mutant enzyme in a mammalian system.
###end p 43
###begin title 44
Properties of p.R39C Mutant Expressed in CHO-K1 Cells
###end title 44
###begin p 45
###xml 522 530 522 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table II</xref>
The p.R369C mutant expressed in mammalian cells was present in amounts similar to the wild-type enzyme (105% of the wild-type enzyme when assessed by Western blotting under denaturing conditions, data not shown). Surprisingly, the amounts of correctly folded tetramers and higher order oligomers were slightly increased to 129% compared with wild-type enzyme after correction for the CBS abundance. However, the relative activity of these correctly folded mutant oligomers was decreased to 54% of the wild-type tetramers (Table II). Taken together the net effect of the p.R369C substitution on quaternary structure and activity appears to be moderate in mammalian cells.
###end p 45
###begin p 46
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 404 407 404 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
###xml 478 479 478 479 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 520 521 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
###xml 544 552 544 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table II</xref>
###xml 572 575 572 575 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">max</sub>
All experiments showed that despite varying extent of correct folding in either the mammalian or prokaryotic system the relative activity of the p.R369C mutant is similarly decreased to about half of the wild-type enzyme. Such behavior of the p.R369C mutant is expected to result from altered kinetic properties. Therefore we determined the Michaelis constant Km for both substrates and we measured the Vmax of reaction in crude CHO cell extracts. The p.R369C mutant exhibited Km for serine and homocysteine similar to Km of the wild-type CBS (Table II). In contrast the Vmax of the mutant was reduced to 29% of the wild-type enzyme and to 55% when corrected for the abundance of tetramers in samples that were used for kinetic studies. Considering the limitations of analyses in crude extracts all these data suggest that the p.R369C mutant does not have lower affinity for its 2 substrates but that the velocity of the reaction is approximately halved.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CBS</italic>
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 370 372 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 327 332 <span type="species:ncbi:4932">yeast</span>
The surprisingly high frequency of the c.1105C>T allele among Norwegian newborns suggests that this CBS mutation may be the most common cause of homocystinuria in North Europeans.12 However, functional studies indicated that it may only be a frequent neutral polymorphism, although the authors discussed a possibility that the yeast may not model this mutation properly.14 Because detailed functional studies and data on frequency in other populations have been lacking, we aimed in our study at exploring the properties of p.R369C mutant enzyme and at determining the prevalence of the c.1105C>T allele in another European population.
###end p 48
###begin p 49
###xml 350 357 350 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table I</xref>
###xml 320 328 <span type="species:ncbi:9606">patients</span>
###xml 359 367 <span type="species:ncbi:9606">patients</span>
###xml 847 852 <span type="species:ncbi:9606">human</span>
From clinical standpoint the question whether the c.1105C>T mutation causes homocystinuria or whether it is only a functionally neutral genetic variant is of key importance. Three lines of evidence support the hypothesis that it is indeed pathogenic. First, this mutation was found at 1 parental allele in 2 independent patients with CBS deficiency (Table I; patients 1 and 2), demonstrating that the p.R369C mutant enzyme produced from the c.1105C>T allele has impaired catalytic activity because it is not able to functionally complement the mutant protein synthesized from the other parental allele. Second, the expression studies presented in this article strongly suggest that the mutant enzyme is intrinsically prone to misfolding but more folding permissive conditions of mammalian cells enable formation of normal amounts of tetramers; in human beings carrying this mutation the tendency to misfold may only manifest under conditions that disfavor folding. Third, regardless of the expression system, the relative activity of p.R369C mutant normalized for tetramer abundance is decreased to about one half of the wild-type enzyme. We have shown that this low activity is not caused by altered binding of substrates but rather by a decreased velocity of the enzymatic reaction.
###end p 49
###begin p 50
###xml 659 661 659 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">22</sup>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr"><sup>22</sup></xref>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 466 474 <span type="species:ncbi:9606">patients</span>
###xml 500 508 <span type="species:ncbi:9606">patients</span>
###xml 739 747 <span type="species:ncbi:9606">patients</span>
###xml 927 935 <span type="species:ncbi:9606">patients</span>
###xml 1125 1133 <span type="species:ncbi:9606">patients</span>
###xml 1274 1279 <span type="species:ncbi:9606">human</span>
The properties of mutant enzyme expressed in cells, however, cannot unequivocally answer the question whether the p.R369C mutation is pathogenic in vivo. The evidence has to come from clinical observations; however, there is a scarcity of reports on CBS-deficient patients carrying the c.1105 C>T variant. This discrepancy between the numbers of expected and reported homozygotes/compound heterozygotes for c.1105 C>T may be due to several reasons, for example, (1) patients may die antenatally, (2) patients may have a phenotypically different disease, which does not resemble homocystinuria (such an example is the mutation p.V377I in mevalonate kinase gene22), (3) the disease manifests in an unrecognized mild adult-onset form, or (4) patients do not have any clinical symptoms at all. The late onset of symptoms, lack of mental retardation, and of connective tissue involvement, and pyridoxine responsiveness in the known patients carrying the p.R369C mutation favor the latter 2 hypotheses of a mild to null phenotype, which possibly escapes diagnosis. It is puzzling that such individuals are not being reported among patients with moderate to severe hyperhomocysteinemia who had been ascertained during a thrombophilia workout. In summary, it is conceivable that in human beings the p.R369C mutation is not functionally neutral in vivo although severity and spectrum of clinical consequences is at present unknown; only future reports on phenotypic features in homozygotes and additional compound heterozygotes carrying this mutation will resolve this issue.
###end p 50
###begin p 51
###xml 258 260 258 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 356 358 356 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 792 794 792 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 1134 1135 1134 1135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 1134 1135 1134 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 1277 1278 1277 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">2</xref>
###xml 1223 1231 <span type="species:ncbi:9606">patients</span>
The second aim of our study was to determine the frequency of c.1105 C>T in another European population. The 0.5% frequency of c.1105 C>T alleles in predominantly Slavic population of the Czech Republic is similar to 0.8% frequency determined by Refsum et al12 in Norwegian newborns or 0.5% shown for 200 North American adult control subjects by Kim et al.14 Although data from other European populations are lacking, similar frequencies in unrelated Norwegians, Czechs, and North Americans suggest that this variant allele may be of ancient origin and that it may be common in populations of European descent. This high population frequency of mutant CBS alleles may have important consequences for newborn screening. The expected frequency of homocystinuria because of 6 mutations in Norway12 and 11 mutations in the Czech Republic (this study) are similarly high, being 1:6400 and 1:15 500, respectively. Provided that p.R369C is indeed pathogenic, the expected frequency of homocystinuria in 2 European populations is similar to the frequency of other common inborn errors of metabolism such as phenylketonuria or MCAD deficiency.7 Such frequency and encouraging efficacy of therapeutic interventions in early detected patients with CBS deficiency (summarized in reference 2) rank thus CBS deficiency among suitable candidates for an efficient newborn screening.
###end p 51
###begin p 52
###xml 313 315 313 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sup>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr"><sup>23</sup></xref>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr"><sup>1</sup></xref>
###xml 483 484 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 659 663 659 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8,23</sup>
###xml 659 663 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib23" ref-type="bibr"><sup>8,23</sup></xref>
###xml 711 713 711 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sup>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr"><sup>24</sup></xref>
###xml 734 736 734 736 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25</sup>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr"><sup>25</sup></xref>
###xml 1380 1388 1380 1388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12,14,26</sup>
###xml 1380 1388 1380 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib14 bib26" ref-type="bibr"><sup>12,14,26</sup></xref>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
###xml 397 405 <span type="species:ncbi:9606">patients</span>
###xml 523 530 <span type="species:ncbi:9606">patient</span>
###xml 606 614 <span type="species:ncbi:9606">patients</span>
###xml 1299 1307 <span type="species:ncbi:9606">patients</span>
Unfortunately, the existing newborn screening programs for CBS deficiency are based on detecting moderately to grossly elevated methionine concentrations by various techniques, including tandem mass spectrometry. It has been shown that patients may not be ascertained if higher cut-off methionine levels are used.23 Especially the pyridoxine-responsive forms, which are present in at least 50% of patients with homocystinuria,1 seem to escape diagnosis by newborn screening programs.7 This is demonstrated by only a single patient with pyridoxine-responsive homocystinuria detected among 36 Irish and U.S. patients that were ascertained in the newborn period.8,23 Total homocysteine measurement in blood samples24 or dried blood spots25 may be a more reliable approach to detecting neonates with homocystinuria. Unfortunately, total homocysteine is not routinely analyzed in newborn screening programs because of the necessity of releasing homocysteine from its bond to plasma proteins in an additional pre-derivatization reduction step. Because cystathionine is decreased and methionine normal to increased in CBS deficiency, the addition of a cystathionine assay with calculation of cystathionine-to-methionine ratio may be an approach for increasing the number of detected presymptomatic newborn patients with homocystinuria. The molecular epidemiology data reported previously12,14,26 and in this study challenge our perception of homocystinuria as a rare disease and should stimulate a discussion on how to increase the efficacy of newborn screening for homocystinuria in populations of European origin.
###end p 52
###begin p 53
###xml 214 215 214 215 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">h</sc>
The authors would like to express their gratitude to Petra Melenovska, MSc, Jana Kopecka, MSc, and Alena Duta for technical help, Marketa Pavlikova, MSc, for calculating the confidence intervals, and J. P. Kraus, PhD, for providing the anti-CBS antibodies.
###end p 53
###begin p 54
Supported by the Wellcome Trust International Senior Research Fellowship in Biomedical Science in Central Europe (reg. No 070255/Z/03/Z). Institutional support was provided by the Research Project of the Ministry of Education of the Czech Republic (reg. No MSM0021620806). The authors declare no conflict of interests.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
Disorders of transsulfuration
###end article-title 56
###begin article-title 57
Cystathionine-beta-synthase and its deficiency
###end article-title 57
###begin article-title 58
Familial thrombophilia associated with homozygosity for the cystathionine beta-synthase 833T->C mutation
###end article-title 58
###begin article-title 59
###xml 76 84 <span type="species:ncbi:9606">patients</span>
The molecular basis of cystathionine beta-synthase deficiency in Australian patients: genotype-phenotype correlations and response to treatment
###end article-title 59
###begin article-title 60
Isolated thrombosis due to the cystathionine beta-synthase mutation c.833T>C (1278T)
###end article-title 60
###begin article-title 61
High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine beta-synthase (CBS) mutations
###end article-title 61
###begin article-title 62
Screening newborns for inborn errors of metabolism by tandem mass spectrometry
###end article-title 62
###begin article-title 63
Newborn screening for homocystinuria: Irish and world experience
###end article-title 63
###begin article-title 64
Prevalence of congenital homocystinuria in Denmark
###end article-title 64
###begin article-title 65
Cystathionine beta-synthase deficiency in Central Europe: discrepancy between biochemical and molecular genetic screening for homocystinuric alleles
###end article-title 65
###begin article-title 66
###xml 45 50 <span type="species:ncbi:9606">human</span>
High prevalence of the I278T mutation of the human cystathionine beta-synthase detected by a novel screening application
###end article-title 66
###begin article-title 67
Birth prevalence of homocystinuria
###end article-title 67
###begin article-title 68
###xml 71 79 <span type="species:ncbi:9606">patients</span>
The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment
###end article-title 68
###begin article-title 69
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine beta-synthase mutation in homocystinuria
###end article-title 69
###begin article-title 70
###xml 38 45 <span type="species:ncbi:9606">patient</span>
###xml 63 70 <span type="species:ncbi:562">E. coli</span>
Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine beta-synthase deficiency
###end article-title 70
###begin article-title 71
Protein measurement with the Folin phenol reagent
###end article-title 71
###begin article-title 72
###xml 29 34 <span type="species:ncbi:9606">human</span>
Cystathionine beta-synthase (human)
###end article-title 72
###begin article-title 73
Structural insights into mutations of cystathionine beta-synthase
###end article-title 73
###begin article-title 74
Structural insights into pathogenic mutations in heme-dependent cystathionine-beta-synthase
###end article-title 74
###begin article-title 75
Correcting temperature-sensitive protein folding defects
###end article-title 75
###begin article-title 76
How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression
###end article-title 76
###begin article-title 77
Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency
###end article-title 77
###begin article-title 78
Reduction of false negative results in screening of newborns for homocystinuria
###end article-title 78
###begin article-title 79
###xml 50 58 <span type="species:ncbi:9606">children</span>
Screening for serum total homocysteine in newborn children
###end article-title 79
###begin article-title 80
Blood spot homocysteine: a feasibility and stability study
###end article-title 80
###begin article-title 81
###xml 50 55 <span type="species:ncbi:9606">human</span>
Haplotyping of wild-type and I278T alleles of the human cystathionine beta-synthase gene based on a cluster of novel SNPs in IVS12
###end article-title 81
###begin p 82
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 380 381 380 381 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 388 389 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sub>
###xml 399 401 399 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sub>
###xml 577 580 577 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(M)</italic>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(WT)</italic>
###xml 611 613 611 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B</italic>
###xml 627 634 627 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 742 781 742 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;Average amount of tetramers/oligomers&#8221;</italic>
###xml 119 126 <span type="species:ncbi:562">E. coli</span>
###xml 627 634 <span type="species:ncbi:562">E. coli</span>
Quaternary structure of p.R369C mutant under different expression conditions. The p.R369C mutant was expressed in both E. coli and CHO cell-based systems, crude extracts were electrophoresed in gradient polyacrylamide gels under non-denaturing conditions followed by Western blotting (see Methods for details). A representative gel is shown, the sharply demarcated fractions (CBS)4, (CBS)8, or (CBS)12 contain 4, 8, or 12 CBS subunits, respectively; the smear in the high molecular weight fraction contains misfolded CBS. The individual lanes contain either the p.R369C mutant (M), wild-type CBS (WT), or blank (B, i.e. either E. coli transformed with empty vector or CHO cells transfected with empty vector pTRE2hyg, respectively). The line "Average amount of tetramers/oligomers" shows the relative amounts of the sum of correctly folded mutant tetramers and oligomers relative to the wild-type CBS enzyme, data are means of 3 independent expressions with SD in parentheses.
###end p 82
###begin p 83
###xml 6 14 <span type="species:ncbi:9606">patients</span>
Known patients with a CBS deficiency carrying the c.1105C>T (p.R369C) mutation
###end p 83
###begin p 84
Allele 1: p.R369C
###end p 84
###begin p 85
Allele 2: p.I278T
###end p 85
###begin p 86
Allele 1: p.R369C
###end p 86
###begin p 87
Allele 2: c.533del18
###end p 87
###begin p 88
Genotypes of both alleles are shown with description of either cDNA nucleotide change (signified by "c.") or of the predicted amino acid substitution (signified by "p.").
###end p 88
###begin p 89
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">4</xref>
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">11</xref>
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
This column shows pyridoxine responsiveness; in references 4 and 11 the vitamin B6 responsiveness is defined as decrease of plasma tHcy below 50 or 60 mumol/L after pyridoxine treatment, respectively.
###end p 89
###begin p 90
Catalytic activity and kinetic properties of the p.R369C mutant
###end p 90
###begin p 91
Numbers shown are means of 3 independent expression experiments with SD.
###end p 91
###begin p 92
###xml 77 78 77 78 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sub>
Numbers shown are means of 2 independent experiments (with the exception of Km for homocysteine, which was determined only once).
###end p 92

